Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 15 | 2026 | 726 | 2.100 |
Why?
|
| Influenza, Human | 10 | 2019 | 294 | 1.490 |
Why?
|
| Pregnancy Complications, Infectious | 7 | 2019 | 157 | 1.450 |
Why?
|
| Influenza Vaccines | 10 | 2020 | 301 | 1.250 |
Why?
|
| Behavior Therapy | 4 | 2024 | 125 | 1.010 |
Why?
|
| Mass Screening | 5 | 2025 | 693 | 0.820 |
Why?
|
| Pregnancy | 21 | 2026 | 1565 | 0.780 |
Why?
|
| Adult | 28 | 2026 | 7621 | 0.760 |
Why?
|
| Syphilis | 1 | 2022 | 16 | 0.750 |
Why?
|
| Papillomavirus Infections | 3 | 2023 | 144 | 0.690 |
Why?
|
| Vaccines | 3 | 2022 | 225 | 0.670 |
Why?
|
| Humans | 38 | 2026 | 17622 | 0.670 |
Why?
|
| Papillomavirus Vaccines | 3 | 2023 | 114 | 0.650 |
Why?
|
| Patient Acceptance of Health Care | 6 | 2022 | 380 | 0.630 |
Why?
|
| Advisory Committees | 5 | 2025 | 112 | 0.620 |
Why?
|
| Breast Feeding | 2 | 2017 | 119 | 0.570 |
Why?
|
| Pregnant Women | 2 | 2019 | 46 | 0.570 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2025 | 368 | 0.570 |
Why?
|
| Syncope | 1 | 2018 | 11 | 0.560 |
Why?
|
| Acute Pain | 1 | 2018 | 11 | 0.550 |
Why?
|
| Exercise | 2 | 2024 | 538 | 0.550 |
Why?
|
| Female | 31 | 2026 | 12715 | 0.540 |
Why?
|
| Adolescent | 14 | 2026 | 3625 | 0.530 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 545 | 0.510 |
Why?
|
| Depression | 4 | 2026 | 507 | 0.510 |
Why?
|
| Health Communication | 1 | 2017 | 16 | 0.500 |
Why?
|
| Physician's Role | 1 | 2017 | 26 | 0.500 |
Why?
|
| Pregnancy Complications | 4 | 2026 | 208 | 0.500 |
Why?
|
| Physicians, Primary Care | 1 | 2017 | 63 | 0.480 |
Why?
|
| United States | 13 | 2026 | 3922 | 0.470 |
Why?
|
| Counseling | 3 | 2022 | 173 | 0.440 |
Why?
|
| Preventive Health Services | 3 | 2022 | 147 | 0.430 |
Why?
|
| Young Adult | 15 | 2025 | 2538 | 0.430 |
Why?
|
| Opioid-Related Disorders | 2 | 2026 | 185 | 0.350 |
Why?
|
| Surveys and Questionnaires | 5 | 2025 | 1296 | 0.340 |
Why?
|
| Infant | 8 | 2026 | 1228 | 0.340 |
Why?
|
| Population Surveillance | 2 | 2023 | 248 | 0.310 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2026 | 323 | 0.290 |
Why?
|
| Anxiety | 2 | 2026 | 162 | 0.270 |
Why?
|
| Depression, Postpartum | 2 | 2019 | 27 | 0.260 |
Why?
|
| Male | 12 | 2026 | 10014 | 0.250 |
Why?
|
| Infant, Newborn | 5 | 2026 | 842 | 0.250 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 527 | 0.240 |
Why?
|
| Child Behavior | 1 | 2026 | 25 | 0.240 |
Why?
|
| Fentanyl | 1 | 2026 | 5 | 0.240 |
Why?
|
| Prospective Studies | 5 | 2019 | 1251 | 0.230 |
Why?
|
| Retrospective Studies | 7 | 2026 | 2502 | 0.220 |
Why?
|
| Adolescent Behavior | 1 | 2026 | 123 | 0.220 |
Why?
|
| Immunization, Secondary | 1 | 2025 | 58 | 0.220 |
Why?
|
| Food Supply | 1 | 2025 | 43 | 0.220 |
Why?
|
| Parents | 2 | 2018 | 301 | 0.220 |
Why?
|
| Anti-Obesity Agents | 1 | 2024 | 18 | 0.210 |
Why?
|
| Antidepressive Agents | 3 | 2023 | 142 | 0.200 |
Why?
|
| Logistic Models | 2 | 2017 | 866 | 0.200 |
Why?
|
| Child | 8 | 2026 | 2485 | 0.200 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2023 | 2 | 0.200 |
Why?
|
| Time Factors | 3 | 2026 | 1038 | 0.200 |
Why?
|
| Oregon | 4 | 2021 | 172 | 0.200 |
Why?
|
| Quality of Life | 2 | 2025 | 505 | 0.200 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2026 | 205 | 0.190 |
Why?
|
| Analgesics, Opioid | 1 | 2026 | 258 | 0.190 |
Why?
|
| Primary Health Care | 2 | 2026 | 729 | 0.190 |
Why?
|
| Pediatric Obesity | 1 | 2024 | 101 | 0.190 |
Why?
|
| Suicide | 1 | 2023 | 116 | 0.180 |
Why?
|
| Middle Aged | 8 | 2025 | 7954 | 0.170 |
Why?
|
| Risk Assessment | 2 | 2023 | 1093 | 0.170 |
Why?
|
| Cohort Studies | 5 | 2026 | 2502 | 0.170 |
Why?
|
| Vaccination Coverage | 1 | 2022 | 63 | 0.170 |
Why?
|
| Bursitis | 1 | 2020 | 4 | 0.160 |
Why?
|
| Shoulder Joint | 1 | 2020 | 6 | 0.160 |
Why?
|
| Respiratory Tract Infections | 2 | 2026 | 59 | 0.160 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2020 | 52 | 0.160 |
Why?
|
| Body Mass Index | 1 | 2024 | 959 | 0.160 |
Why?
|
| Sexual Behavior | 1 | 2020 | 129 | 0.150 |
Why?
|
| Patient Comfort | 1 | 2018 | 3 | 0.140 |
Why?
|
| Cryotherapy | 1 | 2018 | 4 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 319 | 0.140 |
Why?
|
| Interviews as Topic | 2 | 2017 | 324 | 0.140 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 402 | 0.140 |
Why?
|
| Feasibility Studies | 1 | 2018 | 107 | 0.140 |
Why?
|
| Patient Selection | 1 | 2019 | 181 | 0.140 |
Why?
|
| Socioeconomic Factors | 2 | 2017 | 603 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2018 | 214 | 0.130 |
Why?
|
| Washington | 2 | 2021 | 388 | 0.130 |
Why?
|
| Social Marketing | 1 | 2017 | 12 | 0.130 |
Why?
|
| Trust | 1 | 2017 | 33 | 0.120 |
Why?
|
| Educational Status | 1 | 2017 | 177 | 0.120 |
Why?
|
| Hospitalization | 1 | 2021 | 831 | 0.120 |
Why?
|
| Prenatal Care | 2 | 2014 | 129 | 0.110 |
Why?
|
| Bacterial Vaccines | 1 | 2014 | 9 | 0.100 |
Why?
|
| Viral Vaccines | 1 | 2014 | 12 | 0.100 |
Why?
|
| Aged | 5 | 2025 | 6223 | 0.100 |
Why?
|
| Forecasting | 1 | 2013 | 68 | 0.100 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2013 | 96 | 0.090 |
Why?
|
| Health Behavior | 1 | 2014 | 348 | 0.090 |
Why?
|
| Mass Vaccination | 1 | 2011 | 22 | 0.090 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2017 | 540 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 1295 | 0.080 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2011 | 98 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2012 | 135 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2011 | 304 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 302 | 0.070 |
Why?
|
| Registries | 1 | 2011 | 475 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2026 | 1161 | 0.070 |
Why?
|
| Pregnancy Outcome | 2 | 2023 | 162 | 0.070 |
Why?
|
| Incidence | 2 | 2021 | 1278 | 0.060 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2026 | 22 | 0.060 |
Why?
|
| Health Resources | 1 | 2026 | 39 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2026 | 237 | 0.060 |
Why?
|
| Age Factors | 2 | 2020 | 874 | 0.060 |
Why?
|
| California | 3 | 2019 | 2433 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2024 | 1455 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2025 | 121 | 0.050 |
Why?
|
| Weight Reduction Programs | 1 | 2024 | 51 | 0.050 |
Why?
|
| Fear | 1 | 2023 | 14 | 0.050 |
Why?
|
| Upper Extremity | 1 | 2023 | 4 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2023 | 31 | 0.050 |
Why?
|
| Psychotherapy | 1 | 2023 | 56 | 0.050 |
Why?
|
| Telemedicine | 1 | 2026 | 196 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 100 | 0.050 |
Why?
|
| Risk Factors | 2 | 2020 | 3291 | 0.050 |
Why?
|
| Self Report | 1 | 2024 | 262 | 0.050 |
Why?
|
| Family | 1 | 2023 | 111 | 0.050 |
Why?
|
| Suicide, Attempted | 1 | 2023 | 93 | 0.050 |
Why?
|
| Weight Loss | 1 | 2024 | 298 | 0.040 |
Why?
|
| Immunization Programs | 1 | 2022 | 64 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 1976 | 0.040 |
Why?
|
| Child Health Services | 1 | 2022 | 107 | 0.040 |
Why?
|
| Deltoid Muscle | 1 | 2020 | 4 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2020 | 9 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2020 | 102 | 0.040 |
Why?
|
| Sertraline | 1 | 2019 | 2 | 0.040 |
Why?
|
| Family Characteristics | 1 | 2019 | 70 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 631 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2019 | 161 | 0.030 |
Why?
|
| Hispanic Americans | 1 | 2019 | 370 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2019 | 470 | 0.030 |
Why?
|
| Controlled Before-After Studies | 1 | 2016 | 4 | 0.030 |
Why?
|
| Remission Induction | 1 | 2016 | 26 | 0.030 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2016 | 19 | 0.030 |
Why?
|
| Seasons | 1 | 2015 | 116 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 268 | 0.030 |
Why?
|
| Chills | 1 | 2014 | 3 | 0.030 |
Why?
|
| Myalgia | 1 | 2014 | 10 | 0.030 |
Why?
|
| Cough | 1 | 2014 | 20 | 0.030 |
Why?
|
| Preconception Care | 1 | 2014 | 44 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2014 | 85 | 0.030 |
Why?
|
| Chorioamnionitis | 1 | 2014 | 18 | 0.030 |
Why?
|
| Eclampsia | 1 | 2014 | 13 | 0.030 |
Why?
|
| Fever | 1 | 2014 | 52 | 0.030 |
Why?
|
| Contraindications | 1 | 2014 | 14 | 0.030 |
Why?
|
| Vaccines, Inactivated | 1 | 2014 | 73 | 0.030 |
Why?
|
| Pre-Eclampsia | 1 | 2014 | 41 | 0.030 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2014 | 40 | 0.030 |
Why?
|
| Centers for Disease Control and Prevention (U.S.) | 1 | 2013 | 32 | 0.020 |
Why?
|
| Gestational Age | 1 | 2013 | 119 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 446 | 0.020 |
Why?
|
| Smoking | 1 | 2014 | 420 | 0.020 |
Why?
|
| Denmark | 1 | 2012 | 19 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2014 | 354 | 0.020 |
Why?
|
| Focus Groups | 1 | 2012 | 144 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 227 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1107 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2012 | 290 | 0.020 |
Why?
|
| Diabetes, Gestational | 1 | 2014 | 328 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2013 | 719 | 0.020 |
Why?
|
Concepts
(166)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->